Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5905) 5905
Book Chapter (260) 260
Newspaper Article (248) 248
Newsletter (148) 148
Book / eBook (5) 5
Publication (4) 4
Web Resource (4) 4
Dissertation (3) 3
Conference Proceeding (2) 2
Magazine Article (2) 2
Trade Publication Article (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (4724) 4724
humans (4710) 4710
life sciences & biomedicine (4592) 4592
female (3019) 3019
male (2975) 2975
middle aged (2783) 2783
oncology (2568) 2568
lymphoma (2494) 2494
hematology (2430) 2430
adult (2412) 2412
aged (2402) 2402
lymphomas (1614) 1614
prognosis (1548) 1548
biological and medical sciences (1397) 1397
medical sciences (1394) 1394
cancer (1294) 1294
aged, 80 and over (1127) 1127
chemotherapy (1113) 1113
treatment outcome (1097) 1097
hematologic and hematopoietic diseases (1092) 1092
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (1067) 1067
antineoplastic combined chemotherapy protocols - therapeutic use (1010) 1010
care and treatment (917) 917
rituximab (881) 881
retrospective studies (843) 843
non-hodgkin's lymphomas (822) 822
disease-free survival (815) 815
survival rate (809) 809
adolescent (784) 784
transplantation (735) 735
lymphoma, follicular - mortality (721) 721
survival analysis (717) 717
risk factors (712) 712
research (697) 697
tumors (670) 670
neoplasm staging (655) 655
young adult (645) 645
lymphoma, non-hodgkin - mortality (604) 604
patients (594) 594
stem cells (586) 586
health aspects (583) 583
leukemia (580) 580
analysis (571) 571
medicine & public health (560) 560
follow-up studies (552) 552
hemic and lymphatic diseases (547) 547
follicular lymphoma (525) 525
immunology (497) 497
lymphoma, large b-cell, diffuse - mortality (483) 483
abridged index medicus (466) 466
non-hodgkin lymphoma (451) 451
combined modality therapy (446) 446
lymphoma, follicular - drug therapy (440) 440
antineoplastic agents - therapeutic use (435) 435
antineoplastic agents (419) 419
lymphoma, non-hodgkin - drug therapy (414) 414
pathology (414) 414
mortality (409) 409
immunotherapy (408) 408
recurrence (398) 398
lymphoma, follicular - pathology (394) 394
lymphoma, non-hodgkin - therapy (388) 388
diagnosis (383) 383
lymphoma, non-hodgkin - pathology (381) 381
hematology, oncology and palliative medicine (376) 376
medical prognosis (373) 373
patient outcomes (364) 364
cyclophosphamide - administration & dosage (362) 362
survival (361) 361
animals (353) 353
medical research (347) 347
non-hodgkin's lymphoma (347) 347
antineoplastic combined chemotherapy protocols - administration & dosage (344) 344
lymphoma, follicular - therapy (344) 344
transplantation, autologous (336) 336
lymphocytes b (334) 334
antineoplastic combined chemotherapy protocols - adverse effects (331) 331
kaplan-meier estimate (322) 322
child (320) 320
immune system diseases (320) 320
immunohistochemistry (320) 320
epidemiology (318) 318
t cells (313) 313
lymphocytes (306) 306
lymphoma, large b-cell, diffuse - pathology (301) 301
cancer therapies (297) 297
clinical trials (295) 295
incidence (294) 294
bone marrow (292) 292
hematopoietic stem cell transplantation (291) 291
lymphoma - mortality (287) 287
lymphoma, large b-cell, diffuse - drug therapy (287) 287
remission induction (281) 281
stem cell transplantation (280) 280
vincristine - administration & dosage (277) 277
antibodies, monoclonal - therapeutic use (273) 273
doxorubicin - administration & dosage (267) 267
hematopoietic stem cells (267) 267
b-cell lymphoma (265) 265
diffuse large b-cell lymphoma (261) 261
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6520) 6520
German (30) 30
Japanese (27) 27
French (12) 12
Spanish (12) 12
Chinese (7) 7
Italian (6) 6
Russian (6) 6
Portuguese (4) 4
Czech (3) 3
Norwegian (3) 3
Polish (2) 2
Danish (1) 1
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Ocular adnexal follicular lymphoma: A multicenter international study
by Rasmussen, Peter K and Coupland, Sarah E and Finger, Paul T and Graue, Gerardo F and Grossniklaus, Hans E and Honavar, Santosh G and McKelvie, Penny and Mulay, Kaustubh and Prause, Jan U and Ralfkiaer, Elisabeth and Sjö, Lene D and Heegaard, Steffen
JAMA ophthalmology, ISSN 2168-6165, 2014, Volume 132, Issue 7, pp. 851 - 858
Life Sciences & Biomedicine | Ophthalmology | Science & Technology | Eyelid Neoplasms - diagnosis | Lymphoma, Follicular - therapy | Humans | Middle Aged | Lymphoma, Follicular - diagnosis | Male | Antineoplastic Agents - therapeutic use | Lacrimal Apparatus Diseases - therapy | Eye Neoplasms - therapy | Orbital Neoplasms - therapy | Aged, 80 and over | Adult | Female | Retrospective Studies | Biomarkers, Tumor - analysis | Lymphoma, Follicular - mortality | Survival Rate | Combined Modality Therapy | Conjunctival Neoplasms - therapy | Eyelid Neoplasms - therapy | Disease-Free Survival | Eye Neoplasms - diagnosis | Lacrimal Apparatus Diseases - mortality | Eye Neoplasms - mortality | Lacrimal Apparatus Diseases - diagnosis | Proton Therapy | Biopsy | Internationality | Conjunctival Neoplasms - mortality | Orbital Neoplasms - diagnosis | Neoplasm Proteins - analysis | Aged | Orbital Neoplasms - mortality | Neoplasm Staging | Eyelid Neoplasms - mortality | Cohort Studies | Conjunctival Neoplasms - diagnosis
Journal Article
Details down arrow
2. Full Text Transformation of follicular lymphoma
by Lossos, Izidore S and Gascoyne, Randy D
Best practice & research. Clinical haematology, ISSN 1521-6926, 2011, Volume 24, Issue 2, pp. 147 - 163
Hematology, Oncology and Palliative Medicine | DLBCL | follicular lymphoma | transformation | MYC | transplantation | Life Sciences & Biomedicine | Hematology | Science & Technology | Lymphoma, Follicular - therapy | Prognosis | Humans | Salvage Therapy | Transplantation, Autologous | Lymphoma, Large B-Cell, Diffuse - etiology | Burkitt Lymphoma - mortality | Burkitt Lymphoma - pathology | Stem Cell Transplantation | Lymphoma, Large B-Cell, Diffuse - therapy | Lymphoma, Follicular - genetics | Cell Transformation, Neoplastic - genetics | Burkitt Lymphoma - genetics | Lymphoma, Follicular - complications | Burkitt Lymphoma - therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Biomarkers, Tumor - analysis | Lymphoma, Follicular - pathology | Lymphoma, Follicular - mortality | Burkitt Lymphoma - etiology | Disease Progression | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Biopsy | Chromosome Aberrations | Mutation | Cell Transformation, Neoplastic - pathology | Lymphoma, Large B-Cell, Diffuse - genetics | Biomarkers, Tumor - biosynthesis | Research | Non-Hodgkin's lymphomas | Oncology, Experimental | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
by Marcus, Robert and Davies, Andrew and Ando, Kiyoshi and Klapper, Wolfram and Opat, Stephen and Owen, Carolyn and Phillips, Elizabeth and Sangha, Randeep and Schlag, Rudolf and Seymour, John F and Townsend, William and Trněný, Marek and Wenger, Michael and Fingerle-Rowson, Günter and Rufibach, Kaspar and Moore, Tom and Herold, Michael and Hiddemann, Wolfgang
The New England journal of medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 14, pp. 1331 - 1344
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antibodies, Monoclonal, Humanized - adverse effects | Lymphoma, Follicular - drug therapy | Nausea - chemically induced | Humans | Middle Aged | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | Lymphoma, Follicular - mortality | Induction Chemotherapy | Male | Antineoplastic Agents - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Antibodies, Monoclonal, Humanized - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Leukopenia - chemically induced | Aged, 80 and over | Adult | Female | Aged | Immunologic Factors - adverse effects | Rituximab - adverse effects | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Lymphomas | Drug therapy | Observations | Methods | Medical research | Gallium | Rituximab | Cytotoxicity | Nausea | Lymphoma | Cancer therapies | Survival | Studies | Chemotherapy | CD20 antigen | Death | Drug dosages | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Pattern of CD14+ follicular dendritic cells and PD1+ T cells independently predicts time to transformation in follicular lymphoma
by Smeltzer, Jacob P and Jones, Jason M and Ziesmer, Steven C and Grote, Deanna M and Xiu, Bing and Ristow, Kay M and Yang, Zhi Zhang and Nowakowski, Grzegorz S and Feldman, Andrew L and Cerhan, James R and Novak, Anne J and Ansell, Stephen M
Clinical cancer research, ISSN 1078-0432, 06/2014, Volume 20, Issue 11, pp. 2862 - 2872
Life Sciences & Biomedicine | Oncology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antineoplastic agents | Pharmacology. Drug treatments | Immunohistochemistry | Prognosis | Dendritic Cells, Follicular - metabolism | Humans | Middle Aged | Male | Lipopolysaccharide Receptors - metabolism | T-Lymphocytes - metabolism | Aged, 80 and over | Biomarkers, Tumor - metabolism | Adult | Female | T-Lymphocytes - pathology | Biomarkers, Tumor - analysis | Lymphoma, Follicular - pathology | Kaplan-Meier Estimate | Proportional Hazards Models | Lymphoma, Follicular - mortality | Programmed Cell Death 1 Receptor - metabolism | Lipopolysaccharide Receptors - immunology | Cell Transformation, Neoplastic - metabolism | Tumor Microenvironment - immunology | Cell Transformation, Neoplastic - immunology | Dendritic Cells, Follicular - immunology | Lymphoma, Follicular - immunology | Dendritic Cells, Follicular - pathology | T-Lymphocytes - immunology | Aged | Programmed Cell Death 1 Receptor - immunology | Cell Transformation, Neoplastic - pathology | Biomarkers, Tumor - immunology | Index Medicus | CD14 | tumor microenvironment | follicular lymphoma | PD1 | time to transformation
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Follicular lymphoma international prognostic index
by Solal-Céligny, Philippe and Roy, Pascal and Colombat, Philippe and White, Josephine and Armitage, Jim O and Arranz-Saez, Reyes and Au, Wing Y and Bellei, Monica and Brice, Pauline and Caballero, Dolores and Coiffier, Bertrand and Conde-Garcia, Eulogio and Doyen, Chantal and Federico, Massimo and Fisher, Richard I and Garcia-Conde, Javier F and Guglielmi, Cesare and Hagenbeek, Anton and Haïoun, Corinne and LeBlanc, Michael and Lister, Anew T and Lopez-Guillermo, Armando and McLaughlin, Peter and Milpied, Noël and Morel, Pierre and Mounier, Nicolas and Proctor, Stephen J and Rohatiner, Ama and Smith, Paul and Soubeyran, Pierre and Tilly, Hervé and Vitolo, Umberto and Zinzani, Pier-Luigi and Zucca, Emanuele and Montserrat, Emili
Blood, ISSN 0006-4971, 2004, Volume 104, Issue 5, pp. 1258 - 1265
Life Sciences & Biomedicine | Hematology | Science & Technology | Hematologic and hematopoietic diseases | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Multivariate Analysis | Lymphoma, Follicular - therapy | Age Distribution | Prognosis | Humans | Middle Aged | Risk Factors | Lymphoma, Follicular - mortality | Male | Survival Analysis | Adult | Female | Aged | Index Medicus | Abridged Index Medicus | Life Sciences | Other
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States
by Nabhan, Chadi and Byrtek, Michelle and Rai, Ashish and Dawson, Keith and Zhou, Xiaolei and Link, Brian K and Friedberg, Jonathan W and Zelenetz, Andrew D and Maurer, Matthew J and Cerhan, James R and Flowers, Christopher R
British journal of haematology, ISSN 0007-1048, 07/2015, Volume 170, Issue 1, pp. 85 - 95
elderly patients | follicular lymphoma | elderly lymphoma | chemotherapy | rituximab | Follicular lymphoma | Rituximab | Elderly lymphoma | Chemotherapy | Elderly patients | Life Sciences & Biomedicine | Hematology | Science & Technology | United States - epidemiology | Lymphoma, Follicular - therapy | Prognosis | Prospective Studies | Lymphoma, Follicular - pathology | Humans | Middle Aged | Lymphoma, Follicular - mortality | Male | Treatment Outcome | Young Adult | Disease-Free Survival | Lymphoma, Follicular - epidemiology | Aged, 80 and over | Adult | Female | Aged | Cohort Studies | Analysis | Mortality | Lymphomas | Health aspects | Epidemiology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
by Morschhauser, Franck and Fowler, Nathan H and Feugier, Pierre and Bouabdallah, Kamal and Bouabdallah, Reda and Tilly, Hervé and Palomba, M. Lia and Fruchart, Christophe and Libby, Edward N and Casasnovas, Rene-Olivier and Flinn, Ian W and Haioun, Corinne and Maisonneuve, Hervé and Ysebaert, Loic and Bartlett, Nancy L and Brice, Pauline and Ribrag, Vincent and Daguindau, Nicolas and Le Gouill, Steven and Pica, Gian M and Martin Garcia-Sancho, Alejandro and López-Guillermo, Armando and Larouche, Jean-François and Ando, Kiyoshi and Gomes da Silva, Maria and André, Marc and Zachée, Pierre and Sehn, Laurie H and Tobinai, Kensei and Cartron, Guillaume and Liu, David and Wang, Jianming and Xerri, Luc and Salles, Gilles A and RELEVANCE Trial Investigators
The New England journal of medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 10, pp. 934 - 947
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Thalidomide - adverse effects | Skin Diseases - chemically induced | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Lymphoma, Follicular - mortality | Male | Survival Rate | Thalidomide - administration & dosage | Rituximab - administration & dosage | Disease-Free Survival | Thalidomide - analogs & derivatives | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Intention to Treat Analysis | Aged, 80 and over | Adult | Female | Aged | Neutropenia - chemically induced | Rituximab - adverse effects | Chemotherapy | Usage | Lymphomas | Drug therapy | Cancer | Fees & charges | Lymphocytes B | Immunomodulation | Immunotherapy | Advisors | Rituximab | Clinical medicine | Patients | Lymphoma | Neutropenia | Apoptosis | Index Medicus | Abridged Index Medicus | Life Sciences
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Prognostic value of event‐free survival at 12 and 24 months and long‐term mortality for non‐Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group
by Provencio, Mariano and Royuela, Ana and Torrente, María and Pollán, Marina and Gómez‐Codina, José and Sabín, Pilar and Llanos, Marta and Gumá, Josep and Quero, Cristina and Blasco, Ana and Aguiar, David and García‐Arroyo, Francisco Ramón and Lavernia, Javier and Martínez, Natividad and Morales, Manuel and Saenz‐Cusi, Álvaro and Rodríguez, Delvys and Calvo, Virginia and Cruz‐Merino, Luis and Cruz, Miguel Ángel and Rueda, Antonio and Spanish Lymphoma Oncology Grp and Spanish Lymphoma Oncology Group
Cancer, ISSN 0008-543X, 10/2017, Volume 123, Issue 19, pp. 3709 - 3716
follicular lymphoma | mortality | standard mortality ratio | Life Sciences & Biomedicine | Oncology | Science & Technology | Confidence Intervals | Lymphoma, Follicular - drug therapy | Prognosis | Prospective Studies | Age Factors | Humans | Middle Aged | Kaplan-Meier Estimate | Lymphoma, Follicular - mortality | Male | Antineoplastic Agents - therapeutic use | Case-Control Studies | Cause of Death | Disease-Free Survival | Rituximab - therapeutic use | Time Factors | Spain - epidemiology | Sex Factors | Adult | Female | Young adults | Statistical analysis | Mortality | Sex | Population studies | Lymphoma | Survival | Patients | Confidence intervals | Population | Death | Adults | Age | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Rituximab maintenance improves overall survival of patients with follicular lymphoma—Individual patient data meta-analysis
by Vidal, Liat and Gafter-Gvili, Anat and Salles, Gilles and Bousseta, Sami and Oberman, Bernice and Rubin, Carmit and van Oers, Marinus H.J and Fortpied, Catherine and Ghielmini, Michele and Pettengell, Ruth and Witzens-Harig, Mathias and Dreger, Peter and Vitolo, Umberto and Gomes da Silva, Maria and Evangelista, Andrea and Li, Hailun and Freedman, Laurence and Habermann, Thomas M and Shpilberg, Ofer
European journal of cancer (1990), ISSN 0959-8049, 2017, Volume 76, pp. 216 - 225
Hematology, Oncology and Palliative Medicine | Follicular lymphoma | Rituximab | Maintenance | Meta-analysis | Life Sciences & Biomedicine | Oncology | Science & Technology | Immunocompromised Host - immunology | Doxorubicin - therapeutic use | Multivariate Analysis | Cyclophosphamide - administration & dosage | Lymphoma, Follicular - drug therapy | Humans | Middle Aged | Induction Chemotherapy | Male | Antineoplastic Agents - therapeutic use | Cyclophosphamide - therapeutic use | Infection - etiology | Young Adult | Rituximab - therapeutic use | Infection - epidemiology | Aged, 80 and over | Vincristine - administration & dosage | Adult | Female | Maintenance Chemotherapy | Prednisone - administration & dosage | Proportional Hazards Models | Lymphoma, Follicular - mortality | Survival Rate | Randomized Controlled Trials as Topic | Rituximab - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Vincristine - therapeutic use | Aged | Prednisone - therapeutic use | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Medical policy | Patient outcomes | Analysis | Oncology, Experimental | Lymphomas | Research | Epidemiology | Cancer | Therapy | Data analysis | Randomization | Clinical trials | Data processing | Infections | Lymphoma | Patients | Survival | Subgroups | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights